- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Philips Set to Showcase Ultrasound Compact 5500CV at ASE Conference
The new portable ultrasound device, which is being showcased at the American Society of Echocardiography (ASE) conference, offers enhanced cardiac imaging as well as shared transducer interoperability and workflows with existing EPIQ CVx and Affiniti CVx ultrasound systems.
The combination of increasing echocardiography volume and clinician shortages continue to require portable imaging options that can facilitate high quality and efficient ultrasound use at the patient bedside. With these issues in mind, Philips is slated to debut the Ultrasound Compact 5500CV device at the American Society of Echocardiography (ASE) conference this weekend.
One of the features of the Ultrasound Compact 5500CV device is AutoStrain, which provides two-dimensional strain quantification of the left ventricle through robust visualization and analysis, according to Philips.
The company said another benefit of the Ultrasound Compact 5500CV include three-hour battery life that facilitates longer scan times. Philips noted the Ultrasound Compact 5500CV also has transducer interoperability and shared workflow with other Philips ultrasound systems such as EPIQ CVx and Affiniti CVx.
“A key advantage of a portable system is the ability to bring the diagnostic power of echocardiography to (patients) wherever they are in an efficient manner. The image quality of the 5500CV allows us to use this advantage without compromising the certainty of the diagnosis,” noted David Liang, M.D., Ph.D, a professor at Stanford University and director of the Hoag Marfan Syndrome and Related Conditions Program at the Hoag Hospital in Newport Beach, Calif.
(Editor’s note: For related content, see “Pie Medical Imaging Launches AI-Powered Echocardiography Platform” and “Mindray Launches New Handheld Ultrasound Device.”)
Study: AI Boosts Ultrasound AUC for Predicting Thyroid Malignancy Risk by 34 Percent Over TI-RADS
February 17th 2025In a study involving assessment of over 1,000 thyroid nodules, researchers found the machine learning model led to substantial increases in sensitivity and specificity for estimating the risk of thyroid malignancy over traditional TI-RADS and guidelines from the American Thyroid Association.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Emerging PET/CT Agent Shows Promise in Detecting PCa Recurrence in Patients with Low PSA Levels
February 13th 202518F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.
